论文部分内容阅读
据胰岛素敏感指标(ISI)将72例患者分为2组,观察诺和龙对血糖及胰岛素敏感型的改善情况。结果:两组血糖均改善,且无IR组较IR组改善更为明显,有统计学意义。而对胰岛素敏感性的改善无明显差异。结论:诺和龙对无IR的T2DM较有IR的空腹血糖、餐后2h血糖及HbA1c的疗效更佳,但其无改善IR的作用。
72 patients were divided into two groups according to Insulin Sensitivity Index (ISI) to observe the improvement of blood glucose and insulin sensitivity of Novolin. Results: The blood glucose of both groups improved, and there was no significant difference between the two groups in IR group. There was no significant difference in the improvement of insulin sensitivity. CONCLUSION: Novozymes has better fasting blood glucose (IR) than T2DM without IR, and better effect of 2h postprandial blood glucose and HbA1c, but it does not improve IR.